Viral Gene Therapy Market, Global Outlook and Forecast 2022-2028

0
19

This report contains market size and forecasts of Viral Gene Therapy in Global, including the following market information:
Global Viral Gene Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral Gene Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Integrating Viral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Gene Therapy include Lonza, Biogen, Catalent, Gilead Sciences, Sarepta Therapeutics, Novartis, Amgen, Ionis Pharmaceuticals and Spark Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Gene Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral Gene Therapy Market Segment Percentages, by Type, 2021 (%)
Integrating Viral Vectors
Non-Integrating Viral Vectors
Global Viral Gene Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Viral Gene Therapy Market Segment Percentages, by Application, 2021 (%)
Metabolic Diseases
Cardiovascular Diseases
Muscular Diseases
Hematologic Diseases
Ophthalmologic Diseases
Infectious Diseases
Others
Global Viral Gene Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Viral Gene Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Gene Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral Gene Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.